Recombinant DNA Research
Institutional Biosafety Committee (IBC)
Recombinant DNA
CMU and researchers must abide by the National Institutes of Health's Guidelines for Research Involving Recombinant Nucleic Acid Molecules. All projects by the NIH guidelines must be approved by the CMU Institutional Biosafety Committee.
Foust Hall 108C 989-774-7313
Institutional Biosafety Requirements
Central Michigan University requires registration of all biohazardous research and teaching activities with the Institutional Biosafety Committee. In addition to activities covered by the NIH Guidelines for research involving recombinant or synthetic nucleic acid molecules additional covered categories include:
- Agents infectious to humans and other animals.
- Use of human tissues, fluids, or cell lines.
- Lab or field work on animals for which a documented and reasonable potential for transmission of zoonotic agents exists, e.g., wild-trapped rodents, birds, amphibians.
- Lab or field work with the intent to isolate or culture pathogens.
- Research on biological agents that produce harmful toxins, where there is significant potential for human exposure.
- Research involving nanotechnology or other emerging technology that presents a potential hazard/biohazard.
Updated 5/6/2022